SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eric D. Weinhandl, David T. Gilbertson, Allan J. Collins, Robert N. Foley, Relative safety of peginesatide and epoetin alfa, Pharmacoepidemiology and Drug Safety, 2014, 23, 10
  2. You have free access to this content2
    Gary Schneider, Sumesh Kachroo, Natalie Jones, Sheila Crean, Philip Rotella, Ruzan Avetisyan, Matthew W. Reynolds, A systematic review of validated methods for identifying anaphylaxis, including anaphylactic shock and angioneurotic edema, using administrative and claims data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  3. You have free access to this content3
    Gary Schneider, Sumesh Kachroo, Natalie Jones, Sheila Crean, Philip Rotella, Ruzan Avetisyan, Matthew W. Reynolds, A systematic review of validated methods for identifying hypersensitivity reactions other than anaphylaxis (fever, rash, and lymphadenopathy), using administrative and claims data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  4. 4
    Jessica Chubak, Gaia Pocobelli, Noel S. Weiss, Tradeoffs between accuracy measures for electronic health care data algorithms, Journal of Clinical Epidemiology, 2012, 65, 3, 343

    CrossRef

  5. 5
    K. A. Foley, P. F. Wang, B. L. Barber, S. R. Long, J. E. Bagalman, V. Wagner, X. Song, Z. Zhao, Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab, Annals of Oncology, 2010, 21, 7, 1455

    CrossRef

  6. 6
    Teresa L. Kauf, Raymond A. Farkouh, Stephanie R. Earnshaw, Maria E. Watson, Penny Maroudas, Mike G. Chambers, Economic Efficiency of Genetic Screening to Inform the Use of Abacavir Sulfate in the Treatment of HIV, PharmacoEconomics, 2010, 28, 11, 1025

    CrossRef

  7. 7
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2007, 16, 8
  8. 8
    John Seeger, Gregory W. Daniel, Commercial Insurance Databases,